United Health Products, Inc. (UEEC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 80K 160K 240K Q1 '16: 35.8K Q2 '16: 26.9K Q3 '16: 20.8K Q4 '16: 158.5K Q1 '17: 227.1K Q2 '17: 41.8K Q3 '17: 67.6K Q1 '18: 29.9K Q2 '18: 1.9K Q3 '18: 9K Q1 '19: 0 Q2 '19: 4.9K Q3 '19: 0 Q4 '19: 0 Q1 '20: 291 Q2 '20: 136 Q3 '20: 136 Q4 '20: 80 Q1 '21: 59 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 37.5K Q4 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q1 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-80K 0 80K 160K 240K Q1 '13: 0 Q2 '13: 1.4K Q3 '13: 1.6K Q4 '13: 0 Q1 '14: 103.6K Q2 '14: 0 Q3 '14: 0 Q4 '14: -23.9K Q1 '15: 4.8K Q2 '15: 9.5K Q3 '15: 10.1K Q4 '15: 1.3K Q1 '16: 14.7K Q2 '16: 12.7K Q3 '16: 6.8K Q4 '16: 89.9K Q1 '17: 211.7K Q2 '17: 20.5K Q3 '17: 46.3K Q1 '18: 21.1K Q2 '18: 60 Q3 '18: 5.6K Q1 '19: 0 Q2 '19: 4.4K Q3 '19: 0 Q4 '19: -814 Q1 '20: 186 Q2 '20: 80 Q3 '20: 102 Q4 '20: 80 Q1 '21: 34 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 18.9K Q4 '22: 0 Q3 '23: 0 Q4 '23: 0 Q1 '14 Q2 '15 Q3 '16 Q1 '18 Q3 '19 Q4 '20 Q1 '22 Q4 '23

Operating Income Quarterly

-30M -20M -10M 0 10M 20M 30M Q3 '16: -170.8K Q4 '16: -176.4K Q1 '17: 62K Q2 '17: -108.8K Q3 '17: -135.5K Q4 '17: -746.1K Q1 '18: -357.5K Q2 '18: -918.4K Q3 '18: -397.8K Q4 '18: -223.2K Q1 '19: -2.7M Q2 '19: -604.3K Q3 '19: -478.7K Q4 '19: -2.3M Q1 '20: -623.8K Q2 '20: -647.9K Q3 '20: -9.1M Q4 '20: -4.5M Q1 '21: -26.7M Q2 '21: -1.3M Q3 '21: -724.4K Q4 '21: -1.1M Q1 '22: -954.5K Q2 '22: -754.8K Q3 '22: -539.2K Q4 '22: -553.6K Q1 '23: -1.1M Q2 '23: -475.5K Q3 '23: -450.5K Q4 '23: -446.7K Q1 '24: -425.1K Q2 '24: -405.2K Q3 '24: -391.9K Q4 '24: -785.4K Q1 '25: -1.5M Q2 '25: -268.4K Q3 '25: -233.2K Q4 '25: -264.7K Q1 '26: -265.6K Q2 '26: -166.8K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-30M -20M -10M 0 10M 20M 30M Q3 '16: -173.8K Q4 '16: -182.5K Q1 '17: 52K Q2 '17: -119.8K Q3 '17: -140.5K Q4 '17: -1.3M Q1 '18: -4M Q2 '18: -945.5K Q3 '18: -397.8K Q4 '18: -100K Q1 '19: -2.7M Q2 '19: -807.1K Q3 '19: -524.9K Q4 '19: -2.6M Q1 '20: -625.8K Q2 '20: -693.1K Q3 '20: -9.2M Q4 '20: -5.2M Q1 '21: -27M Q2 '21: -1.3M Q3 '21: -724.4K Q4 '21: -1.5M Q1 '22: -964.3K Q2 '22: -879K Q3 '22: 820.6K Q4 '22: -664.8K Q1 '23: -1.1M Q2 '23: -522.9K Q3 '23: -485.7K Q4 '23: -471.9K Q1 '24: -451.9K Q2 '24: -432K Q3 '24: -303.7K Q4 '24: -814.1K Q1 '25: -1.5M Q2 '25: -315.2K Q3 '25: -285.6K Q4 '25: -536.9K Q1 '26: -315.8K Q2 '26: -284.1K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 30K 60K 90K Q2 '10: 0 Q2 '11: 0 Q3 '17: 21.3K Q4 '17: 9.1K Q1 '18: 8.9K Q2 '18: 1.8K Q3 '18: 3.5K Q4 '18: 82.6K Q1 '19: 0 Q2 '19: 502 Q3 '19: 0 Q4 '19: 814 Q1 '20: 105 Q2 '20: 56 Q3 '20: 34 Q1 '21: 25 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 18.6K Q4 '22: 0 Q3 '23: 0 Q4 '23: 0 Q2 '10 Q1 '18 Q1 '19 Q1 '20 Q2 '21 Q2 '22 Q4 '23

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '16: -158.8K Q4 '16: -160.5K Q1 '17: -93.2K Q2 '17: -52.2K Q3 '17: -150.2K Q4 '17: -354.1K Q1 '18: -318.4K Q2 '18: -309K Q3 '18: -273.4K Q4 '18: -377.9K Q1 '19: -221K Q2 '19: -612.2K Q3 '19: -412.7K Q4 '19: -521K Q1 '20: -503.5K Q2 '20: -400.9K Q3 '20: -276.2K Q4 '20: -145.4K Q1 '21: -110.5K Q2 '21: -153.1K Q3 '21: -194.1K Q4 '21: -370.4K Q1 '22: -195.7K Q2 '22: -203.5K Q3 '22: -2.1K Q4 '22: -218.4K Q1 '23: -548.1K Q2 '23: -471.2K Q3 '23: -604.8K Q4 '23: -576.5K Q1 '24: -405.8K Q2 '24: -287.7K Q3 '24: -319.8K Q4 '24: -181.4K Q1 '25: -274K Q2 '25: -184.7K Q3 '25: -175.2K Q4 '25: -553.1K Q1 '26: -84.3K Q2 '26: -138K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '19: -412.7K Q4 '19: -521K Q3 '20: -281.2K Q4 '20: -154.6K Q3 '21: -194.1K Q4 '21: -370.4K Q3 '19 Q4 '19 Q3 '20 Q4 '20 Q3 '21 Q4 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 100M 200M 300M Q3 '22: 279.7M Q1 '23: 233.3M Q2 '23: 238.3M Q3 '23: 241.5M Q1 '24: 245.8M Q2 '24: 247.7M Q3 '24: 248.6M Q1 '25: 254.6M Q2 '25: 257.1M Q3 '25: 257.8M Q1 '26: 258.7M Q2 '26: 260M Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.24 -0.16 -0.08 0.00 0.08 0.16 0.24 Q1 '14: -0.01 Q2 '14: -0.01 Q3 '14: -0.01 Q4 '14: -0.02 Q1 '15: -0.03 Q2 '15: -0.03 Q3 '15: -0.03 Q4 '15: -0.01 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: -0.01 Q1 '18: -0.03 Q2 '18: -0.04 Q3 '18: -0.04 Q4 '18: -0.03 Q1 '19: -0.03 Q2 '19: -0.02 Q3 '19: -0.02 Q4 '19: -0.04 Q1 '20: -0.02 Q2 '20: -0.02 Q3 '20: -0.07 Q4 '20: -0.08 Q1 '21: -0.20 Q2 '21: -0.21 Q3 '21: -0.16 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.02 Q4 '25: -0.01 Q1 '26: 0.00 Q2 '26: 0.00 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.